Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Hypertension 1Glioblastoma 1Cognitive Dysfunction 1Brain Neoplasms 1

Interventions

Memantine 2acetaminophen, aspirin, caffeine drug combination 1Transcranial Direct Current Stimulation 1Time 1Sugars 1Sirolimus 1Riluzole 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Palliative Care 1Ibuprofen 1Exercise 1Donepezil 1Cognitive Behavioral Therapy 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cognitive Dysfunction × Ramipril × Clear all
NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Wake Forest University Health Sciences

Phase 2 Completed
75 enrolled 47 charts
CNS

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡